Bieżący numer
Archiwum
Online first
O czasopiśmie
Redakcja
Rada Naukowa
Wydawca
Standardy etyczne i procedury
Bazy indeksacyjne
Recenzenci
Recenzenci Honorowi
Prenumerata
Kontakt
Najczęściej czytane artykuły
Dla autorów
Opłata za przetwarzanie artykułu (APC)
Książki i Konferencje
Książki
Konferencje
SARS CoV-2/COVID-19
PRACA ORYGINALNA
Impact of COVID-19 on inflammatory disease research: a literature analysis of 77,575 PubMed articles
1
The Japanese Society of Internal Medicine, Japan
Data nadesłania: 21-08-2025
Data ostatniej rewizji: 29-09-2025
Data akceptacji: 08-10-2025
Data publikacji: 27-02-2026
Autor do korespondencji
Reumatologia 2026;64(1):17-27
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Objectives:
This study investigated how the coronavirus disease 2019 (COVID-19) pandemic influenced research trends related to inflammatory diseases and biomarkers. By analyzing large-scale bibliographic data, the study aimed to clarify thematic transitions over the past 3 decades and to identify emerging perspectives that shape current and future directions.
Material and methods:
PubMed-indexed articles (n = 77,575) published from 1995 to 2024 were examined using Python (Version 3.10.5) in a PyCharm (Software Version 2022.1.3) environment. Titles, abstracts, and key words were preprocessed by removing stop words and symbols, and the 50 most frequent terms were extracted. A key word co-occurrence matrix was constructed to evaluate relationships between terms, and heatmaps were generated for visualization. To capture developmental stages, the dataset was divided into 3 periods (1995–2004, 2005–2014, 2015–2024), and thematic shifts were compared across intervals.
Results:
The analysis revealed distinct transitions. From 1995 to 2004, research emphasized immune pathways and molecular mechanisms. Between 2005 and 2014, the focus shifted toward translational and clinical applications. After 2015, particularly during the COVID-19 era, biomarker studies expanded into public health, epidemiology, and infection monitoring.
Conclusions:
Biomarker research in inflammatory diseases has progressed from molecular inquiry to clinical translation and now to population-level health strategies. The COVID-19 pandemic accelerated this trajectory, positioning biomarkers as pivotal tools that link laboratory science with public health preparedness and policy. Beyond clarifying historical shifts, this study demonstrates how quantitative bibliometric analysis can reveal overlooked relationships between research domains and highlight emerging perspectives. Such findings not only inform scientific agendas but also guide policymakers in strengthening healthcare systems. By framing biomarkers as both scientific markers and societal instruments, this study underscores their transformative role and offers a comprehensive foundation for shaping future investigations.
This study investigated how the coronavirus disease 2019 (COVID-19) pandemic influenced research trends related to inflammatory diseases and biomarkers. By analyzing large-scale bibliographic data, the study aimed to clarify thematic transitions over the past 3 decades and to identify emerging perspectives that shape current and future directions.
Material and methods:
PubMed-indexed articles (n = 77,575) published from 1995 to 2024 were examined using Python (Version 3.10.5) in a PyCharm (Software Version 2022.1.3) environment. Titles, abstracts, and key words were preprocessed by removing stop words and symbols, and the 50 most frequent terms were extracted. A key word co-occurrence matrix was constructed to evaluate relationships between terms, and heatmaps were generated for visualization. To capture developmental stages, the dataset was divided into 3 periods (1995–2004, 2005–2014, 2015–2024), and thematic shifts were compared across intervals.
Results:
The analysis revealed distinct transitions. From 1995 to 2004, research emphasized immune pathways and molecular mechanisms. Between 2005 and 2014, the focus shifted toward translational and clinical applications. After 2015, particularly during the COVID-19 era, biomarker studies expanded into public health, epidemiology, and infection monitoring.
Conclusions:
Biomarker research in inflammatory diseases has progressed from molecular inquiry to clinical translation and now to population-level health strategies. The COVID-19 pandemic accelerated this trajectory, positioning biomarkers as pivotal tools that link laboratory science with public health preparedness and policy. Beyond clarifying historical shifts, this study demonstrates how quantitative bibliometric analysis can reveal overlooked relationships between research domains and highlight emerging perspectives. Such findings not only inform scientific agendas but also guide policymakers in strengthening healthcare systems. By framing biomarkers as both scientific markers and societal instruments, this study underscores their transformative role and offers a comprehensive foundation for shaping future investigations.
REFERENCJE (20)
1.
Luo H. Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: a systemic analysis of the Global Burden of Disease Study 2021. Autoimmun Rev 2024; 23: 103639, DOI: 10.1016/j.autrev.2024.103639.
2.
Acencio ML, Ostaszewski M, Mazein A, et al. The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease. Front Immunol 2023; 14: 1257321, DOI: 10.3389/fimmu.2023.1257321.
3.
Pritzker KPH. Blood-based biomarkers of chronic inflammation. Expert Rev Mol Diagn 2023; 23: 495–504, DOI: 10.1080/14737159.2023.2215928.
4.
Ahmad A, Imran M, Ahsan H. Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases. Pharmaceutics 2023; 15: 1630, DOI: 10.3390/pharmaceutics15061630.
5.
Harris DMM, Szymczak S, Schuchardt S, et al. Tryptophan degradation as a systems phenomenon in inflammation – an analysis across 13 chronic inflammatory diseases. EBioMedicine 2024; 102: 105056, DOI: 10.1016/j.ebiom.2024.105056.
6.
Xue C, Li G, Zheng Q, et al. Tryptophan metabolism in health and disease. Cell Metab 2023; 35: 1304–1326, DOI: 10.1016/j.cmet.2023.06.004.
7.
Aliyu M, Zohora FT, Anka AU, et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol 2022; 111: 109130, DOI: 10.1016/j.intimp.2022.109130.
8.
Qiu S, Cai Y, Yao H, et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther 2023; 8: 132, DOI: 10.1038/s41392-023-01399-3.
9.
Stafford IS, Kellermann M, Mossotto E, et al. A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases. NPJ Digit Med 2020; 3: 30, DOI: 10.1038/s41746-020-0229-3.
10.
Ng S, Masarone S, Watson D, Barnes MR. The benefits and pitfalls of machine learning for biomarker discovery. Cell Tissue Res 2023; 394: 17–31, DOI: 10.1007/s00441-023-03816-z.
11.
Ogasawara N, Matsunaga K, Isomoto H, Shimizu W. Internal medicine year in review 2022. Intern Med 2023; 62: 3431–3435, DOI: 10.2169/internalmedicine.2266-23.
12.
Patrascu R, Dumitru CS. Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients. J Clin Med 2025; 14: 1475, DOI: 10.3390/jcm14051475.
13.
Semiz S. COVID19 biomarkers: what did we learn from systematic reviews? Front Cell Infect Microbiol 2022; 12: 1038908, DOI: 10.3389/fcimb.2022.1038908.
14.
Caruso FP, Scala G, Cerulo L, Ceccarelli M. A review of COVID-19 biomarkers and drug targets: resources and tools. Brief Bioinform 2021; 22: 701–713, DOI: 10.1093/bib/bbaa328.
15.
Zhou Q, Leydesdorff L. The normalization of occurrence and co-occurrence matrices in bibliometrics using cosine similarities and Ochiai coefficients. J Assoc Inf Sci Tech 2016; 67: 2805–2814.
16.
Kontostathis A, Pottenger WM. A Mathematical View of Latent Semantic Indexing: Tracing Term Co-occurrences. Proceedings of the 2002 ACM Symposium on Applied Computing 2002; 391–395.
17.
Becker KG, Hosack DA, Dennis G Jr, et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 2003; 4: 61, DOI: 10.1186/1471-2105-4-61.
18.
Blei DM, Ng AY, Jordan MI. Latent dirichlet allocation. J Mach Learn Res 2003; 3: 993–1022.
19.
Meier L, Van De Geer S, Bühlmann P. The Group Lasso for Logistic Regression. J R Stat Soc Series B Stat Methodol 2008; 70: 53–71, DOI: 10.1111/j.1467-9868.2007.00627.x.
20.
van Eck NJ, Waltman L. Visualizing Bibliometric Networks. In: Ding Y, Rousseau R, Wolfram D (eds.). Measuring Scholarly Impact. Springer, Cham 2014.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
ARTYKUŁ POWIĄZANY
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
Przetwarzamy dane osobowe zbierane podczas odwiedzania serwisu. Realizacja funkcji pozyskiwania informacji o użytkownikach i ich zachowaniu odbywa się poprzez dobrowolnie wprowadzone w formularzach informacje oraz zapisywanie w urządzeniach końcowych plików cookies (tzw. ciasteczka). Dane, w tym pliki cookies, wykorzystywane są w celu realizacji usług, zapewnienia wygodnego korzystania ze strony oraz w celu monitorowania ruchu zgodnie z Polityką prywatności. Dane są także zbierane i przetwarzane przez narzędzie Google Analytics (więcej).
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
